BRD4 binds fedratinib

Stable Identifier
R-HSA-9680408
Type
Reaction [binding]
Species
Homo sapiens
Compartment
nucleoplasm
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
BRD4 binds fedratinib
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Bromodomain-containing protein 4 (BRD4) binds inhibitory small molecules including fedratinib, modifying or inhibiting its role in histone code reading via recognition of acetylated histones (Lucas et al. 2013). Fedratinib also binds and inhibits JAK2 (Ciceri et al. 2014), raising the possibility that this drug might target two aspects of host responses to coronavirus infection.

Literature References
PubMed ID Title Journal Year
24584101 Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

Knapp, S, Fedorov, O, Filippakopoulos, P, Wells, C, O'Mahony, A, Wodicka, LM, Martin, S, Shah, NP, Hunt, JP, Picaud, S, Ciceri, P, Lasater, EA, Pallares, G, Treiber, DK, Müller, S

Nat. Chem. Biol. 2014
24272870 4-Acyl pyrroles: mimicking acetylated lysines in histone code reading

Lucas, X, Jung, M, Schüle, R, Wohlwend, D, Günther, S, Gerhardt, S, Schmidtkunz, K, Hügle, M, Einsle, O

Angew. Chem. Int. Ed. Engl. 2013
Participants
Input
Output
Participates
as an event of
Authored
Jassal, B  (2020-03-27)
Reviewed
Shoichet, BK  (2020-05-14)
Created
Jassal, B  (2020-03-27)
Cite Us!